CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum's disease treatment. - CBL-514 received both FDA Orphan Drug Designation and Fast Track designation for Dercum's ...
Report Ocean has published a new report on the Facial Injectable Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...